News Focus
News Focus
Followers 16
Posts 1898
Boards Moderated 0
Alias Born 05/12/2016

Re: HighGround post# 127203

Friday, 05/14/2021 3:02:09 PM

Friday, May 14, 2021 3:02:09 PM

Post# of 140539
Who are they? A couple snippets/links...

https://www.businesswire.com/news/home/20190501005113/en/Titan-Medical-Names-Prominent-Medical-Technology-Executive-Charles-Federico-as-Chairman-of-the-Board

https://www.mpo-mag.com/contents/view_breaking-news/2019-06-14/titan-medical-names-prominent-medical-technology-executive-as-board-chairman/

Federico has 46 years of experience in the medical device industry. As a director of MAKO Surgical Corp., he served as chairman, lead director, Compensation Committee chairman, Governance Committee chairman and an Audit Committee member from 2007 to 2013. MAKO, a developer of minimally invasive robotic-enabled techniques for knee surgery, was acquired by Stryker Corp. in 2013 for $1.65 billion.

https://www.linkedin.com/in/john-schellhorn-57a6998

John Schellhorn is the President and CEO of Monteris Medical.
Prior to joining Monteris, John served as the Chief Commercialization Officer for BARRX Medical, and as President and CEO of Softscope Medical Technologies Inc. Both companies were successfully acquired by strategic partners during his tenure.
Prior to Softscope, John held positions as Vice President of Sales and Marketing for the Peripheral Vascular Division of ev3 Inc., Vice President and General Manager International for ACMI Corporation, and various management positions within Boston Scientific.

Mr. McNally said "I would like to thank Charlie and John for their many contributions to our Board, and for their guidance in securing this important strategic relationship. We wish them continued success."


I'm guessing their work was completed as of the announcement of the agreement on June 4, 2020.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today